Navigation Links
Varian, Inc. Acquires Oxford Diffraction, Ltd.
Date:4/6/2008

PALO ALTO, Calif., April 7, 2008 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today that it has acquired Oxford Diffraction, Ltd., a privately owned company based in Abingdon, U.K. Oxford Diffraction is a leader in x-ray crystallography, an analytical technique used by scientists in pharmaceutical research and other research laboratories to determine the structure of both small molecules and large molecules such as proteins.

For crystalline compounds, x-ray crystallography is the most powerful technique available for structural analysis. Nuclear magnetic resonance (NMR) provides complementary structural information for compounds in the solid state and also structural information for compounds in solutions.

"The acquisition of Oxford Diffraction is key to Varian's goal of broadening its range of information-rich detection products for life science research," said Garry W. Rogerson, President and CEO, Varian, Inc. "Oxford Diffraction has experienced rapid growth since its formation in 2001 and has established a strong reputation in single crystal X-ray crystallography, particularly in Europe. Oxford Diffraction products will now be distributed on a global basis via Varian's worldwide distribution network."

"In addition to the obvious benefit to our business of a much larger distribution and support organization, the sale of Oxford Diffraction to Varian brings a number of additional important advantages," said Paul Loeffen CEO of Oxford Diffraction. "We now have the opportunity to offer customers more powerful solutions through combinations of complementary information-rich techniques to include X-ray crystallography, nuclear magnetic resonance (NMR) spectrometry and liquid chromatography-mass spectrometry (LC-MS). Furthermore, as part of Varian, we look forward to continuing the development of innovative technologies and products for our customers."

"Existing Oxford Diffraction customers will continue to benefit from the same dedicated and attentive customer support and applications team at Oxford Diffraction but with the additional resources of Varian's worldwide support organization," said David Warner, Customer Support Group Manager at Oxford Diffraction. "One of our strengths has been a tailored and personal support experience for our customers. This will not change since our customers will be dealing with the same people. The support of the Varian network will simply enhance this experience."

Varian, Inc. acquired Oxford Diffraction for approximately $37 million in cash and assumed net debt (subject to certain net asset adjustments). The transaction also includes an opportunity for additional purchase price payments over three years, dependent on future financial performance. Those future payments could total up to $10 million if aggressive performance targets are achieved. Oxford Diffraction generated revenues of approximately $15 million for the twelve months ended March 31, 2008. Varian, Inc. will provide further details on the acquisition during its webcast conference call to review its fiscal year 2008 second quarter financial results later this month.

This acquisition is part of Varian, Inc.'s strategy to strengthen the company's portfolio of information-rich detection products, through internal research and development as well as the acquisition of complementary products and technologies.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For More Information, Contact:

Investor Relations

Varian, Inc.

650.424.5471

ir@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
2. Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides.
3. Varian, Inc. Acquires Analogix Business
4. Varian, Inc. CEO to Speak at JPMorgan Healthcare Conference
5. Varian, Inc. Board Authorizes New $100 Million Stock Repurchase Program
6. New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications
7. New Ion Trap Mass Spectrometers From Varian, Inc. Offer the Ultimate in Sensitive Detection and High Productivity
8. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
9. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
10. Food Bank For New York City Acquires FoodChange
11. Concentra Acquires Assets of Renew Health & Wellness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
(Date:10/12/2017)... ... 12, 2017 , ... Farm Forward joins Bon ... leading institutions in announcing the launch of the Leadership Circle , a ... are raised for food. , Founding members of the Leadership Circle also include ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
(Date:10/7/2017)... Oct. 6, 2017   Provista, a proven ... $100 billion in purchasing power, today announced a new ... The Newsroom is the online home for ... infographics, expert bios, news releases, slideshows and events. ... a wealth of resources at their fingertips, viewers can ...
Breaking Medicine Technology: